Cancer Research The Future of Cancer Research: Science and Patient Impact  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 41, 3799-3802, September 1, 1981]
© 1981 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Harmony, J. A. K.
Right arrow Articles by Hui, D. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harmony, J. A. K.
Right arrow Articles by Hui, D. Y.

Inhibition by Membrane-bound Low-Density Lipoproteins of the Primary Inductive Events of Mitogen-stimulated Lymphocyte Activation1

Judith A. K. Harmony2 and David Y. Hui3

Chemistry Department, Indiana University, Bloomington, Indiana 47405

Low-density lipoproteins (LDL) inhibit phytohemagglutinin (PHA)-enhanced accumulation of calcium ion and cyclic guanosine 3':5'-monophosphate, and phosphatidylinositol turnover in human lymphocytes. Inhibition by LDL of PHA-induced 32P incorporation into monophosphoinositide and cyclic guanosine 3':5'-monophosphate accumulation correlates directly with inhibition by LDL of calcium ion accumulation. These results suggest that calcium ion accumulation is required for PHA to direct turnover of monophosphoinositide and cyclic guanosine 3':5'-monophosphate synthesis in lymphocytes and that inhibition of this mitogen-induced response by LDL may be a direct consequence of the ability of these lipoproteins to prevent calcium ion accumulation by the activated cells. The ability of LDL to suppress PHA-enhanced calcium ion accumulation is directly proportional to the amount of LDL localized at the cell surface, indicating that internalization of the lipoproteins is not required for immunoregulation. This conclusion is supported by two additional lines of evidence: (a) LDL depleted of the bioregulatory constituent cholesterol are as effective as are native LDL in suppressing lymphocyte response to PHA; and (b) LDL-Sepharose complexes which cannot be endocytosed by the cells are as immunosuppressive as soluble LDL. The data clearly establish that membrane-bound LDL may have a regulatory role.

1 Presented at the Workshop on Fat and Cancer, December 10 to 12, 1979, Bethesda, Md. This research was supported by USPHS Grant HL 20882 from NIH and by Grant 79-1072 from the American Heart Association.

2 Presented address: Department of Biological Chemistry, University of Cincinnati College of Medicine, 231 Bethesda Ave., Cincinnati, Ohio 45267. To whom requests for reprints should be addressed.

3 Recipient of USPHS Traineeship GM07227 in Molecular and Cellular Biology.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1981 by the American Association for Cancer Research.